BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Scient'x Groupe, S.A. Appointing Spinal Orthopedic Industry Executive Oliver Burckhardt as President and Chief Executive Officer


4/28/2009 8:02:36 AM

PARIS, April 27 /PRNewswire/ -- Scient'x Groupe, S.A. announced today that veteran industry executive Oliver Burckhardt is joining the company as its President and Chief Executive Officer following the retirement from the Company of Michael D. Huggins.

Mr. Burckhardt was formerly President of Orthofix Spine, Inc. and was responsible for the global Spine business units, where revenues exceeded US$100 million in 2008. Prior to Orthofix, Mr. Burckhardt was with Aesculap, where he served as the Vice President of Spine Sales and Marketing and played a key role in building the USA and international Aesculap spine business from start-up. His experience includes developing and commercializing spinal implants, M&A, initiating marketing strategies and establishing meaningful relationships with leading spine surgeons throughout the world. Well respected throughout the industry, his balance of U.S. and international market development experience in spine is uniquely suited to leverage Scient'x's core competencies in motion preservation and fusion.

Mr. Burckhardt stated, "I am excited to join this global organization with a 20-year history of developing truly innovative products and clinical solutions for spine surgeons and their patients. I look forward to collaborating with its surgeon customers and working with their world class team to leverage the Company's strengths."

"Oliver Burckhardt is a highly respected executive who will continue to grow the Scient'x global franchise. His experience in driving innovative product development will build on the Company's reputation for innovation," said Michael D. Huggins, retiring President and Chief Executive Officer.

"During his tenure as President and Chief Executive Officer of Scient'x, Mike Huggins strengthened the platform and positioned the Company for significant growth. His many achievements have been substantive and include development and mining of key clinical data, a successful restructuring of Scient'x USA operations, compliance upgrades, expansion of the global scientific advisory board and building out the research and development team. We are deeply appreciative of the contributions he has made. Looking forward, we are confident that Oliver's experience and abilities will serve the Company well as we begin this exciting new chapter at Scient'x. As a result of this event and the Company's conservative cash management processes, our funds have made a significant incremental investment in the company to support ongoing product and business development and clinical data initiatives," stated Mortimer Berkowitz III, Chairman of Scient'x.

ABOUT SCIENT'X

Based in Paris, France, Scient'x is the largest independent spinal implant company outside of the United States. The Company designs, develops and distributes an extensive line of spine surgical implants in over 50 countries around the world. For over 20 years, Scient'x has been a pioneer in all aspects of spinal instrumentation including the motion preservation segment of the spine market. The Company was the first to introduce PEEK implants to spinal surgery as well as posterior dynamic stabilization technology. Scient'x has now introduced a second generation ceramic cervical disc that has achieved significant revenue traction and surgeon acceptance globally.

CONTACT: Mr. Oliver Burckhardt, President and Chief Executive Officer of
SCIENT'X, +33-139-306-930, o.burckhardt@scientx.com ; or Mr. Mortimer "Tim"
Berkowitz III, President, tberkowitz@healthpointcapital.com; or Mr. John
McCormick, Managing Director, jmccormick@healthpointcapital.com, both of
HealthpointCapital, LLC, +1-212-935-7780



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES